VOLITIONRX LTD — Director's Dealing 2015

Aug 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-08-17

Reporting Person: KRATOCHVIL DAVID MATTHEW (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-17	Stock Option	$3.75	A	75000	Acquired	2020-08-17	Common Stock (75000)	Direct

Footnotes

F1: A total of 75,000 Options were granted on August 17, 2015 under the Company's 2011 Equity Incentive Plan. The Options vest in full on the date of grant.